A simple method for eliminating fixed-region interference of aptamer binding during SELEX

Biotechnology and Bioengineering

Volumn 111, Issue 11, 2014, Pages 2265-2279

[No Author Info available]

Author keywords

Aptamer; DNA aptamer; Nucleic acids; Polymerase chain reaction; RNA aptamer; SELEX; Therapeutics

Indexed keywords

BINDING ENERGY; BINS; CALORIMETERS; CALORIMETRY; ENDOTHELIAL CELLS; ENZYMES; FUNCTIONAL POLYMERS; ISOTHERMS; LIBRARIES; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PROTEINS; TITRATION;

APTAMERS; DNA APTAMER; RNA APTAMER; SELEX; THERAPEUTICS;

POLYMERASE CHAIN REACTION;

APTAMER; GUANINE QUADRUPLEX; OLIGONUCLEOTIDE; STREPTAVIDIN; THROMBIN; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; COMBINATORIAL CHEMISTRY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DNA FLANKING REGION; ENTHALPY; ENTROPY; FIXED REGION MEDIATED INTERFERENCE; HUMAN; HYBRIDIZATION; ISOTHERMAL TITRATION CALORIMETRY; LIMIT OF DETECTION; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STANDARD; STEREOSPECIFICITY; BIOLOGY; CALORIMETRY; GENETICS; METABOLISM; PROCEDURES;

APTAMERS, NUCLEOTIDE; CALORIMETRY; COMPUTATIONAL BIOLOGY; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SELEX APTAMER TECHNIQUE; STREPTAVIDIN; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907898820     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25294     Document Type: Article

References (70)

1. Ahmad KM, Oh SS, Kim S, McClellen FM, Xiao Y, Soh HT. 2011. Probing the limits of aptamer affinity with a microfluidic SELEX platform. PLoS ONE 6(11):e27051.
2. Baker BR, Lai RY, Wood MS, Doctor EH, Heeger AJ, Plaxco KW. 2006. An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids. J Am Chem Soc 128(10):3138-3139.
3. Berezovski MV, Musheev MU, Drabovich AP, Jitkova JV, Krylov SN. 2006. Non-SELEX: Selection of aptamers without intermediate amplification of candidate oligonucleotides. Nat Protoc 1(3):1359-1369.
4. Bing T, Yang X, Mei H, Cao Z, Shangguan D. 2010. Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem 18(5):1798-1805.
5. Bless NM, Smith D, Charlton J, Czermak BJ, Schmal H, Friedl HP, Ward PA. 1997. Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol 7(11):877-880.
6. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. 1992. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355(6360):564-566.
7. Chang Y-C, Kao W-C, Wang W-Y, Wang W-Y, Yang R-B, Peck K. 2009. Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses. FASEB J 23(9):3078-3088.
8. Charlton J, Sennello J, Smith D. 1997. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 4(11):809-816.
9. Cho M, Soo Oh S, Nie J, Stewart R, Eisenstein M, Chambers J, Marth JD, Walker F, Thomson JA, Soh HT. 2013. Quantitative selection and parallel characterization of aptamers. Proc Natl Acad Sci USA 110(46):18460-18465.
10. Choi EW, Nayak LV, Bates PJ. 2010. Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Res 38(5):1623-1635.
11. Civit L, Fragoso A, O'Sullivan CK. 2012. Evaluation of techniques for generation of single-stranded DNA for quantitative detection. Anal Biochem 431(2):132-138.
12. Cox JC, Hayhurst A, Hesselberth J, Bayer TS, Georgiou G, Ellington AD. 2002. Automated selection of aptamers against protein targets translated in vitro: From gene to aptamer. Nucleic Acids Res 30(20):e108.
13. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. 2003. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 100(26):15416-15421.
14. Djordjevic M. 2007. SELEX experiments: New prospects, applications and data analysis in inferring regulatory pathways. Biomol Eng 24(2):179-189.
15. Dua P, Kang HS, Hong S-M, Tsao M-S, Kim S, Lee D-k. 2013. Alkaline phosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein. Cancer Res 73(6):1934-1945.
16. Ellington AD, Szostak JW. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346(6287):818-822.
17. Fang X, Cao Z, Beck T, Tan W. 2001. Molecular aptamer for real-time oncoprotein platelet-derived growth factor monitoring by fluorescence anisotropy. Anal Chem 73(23):5752-5757.
18. Gold L, Janjic N. US Patent 5, 811, 533. Assignee 1998 Sep. 22, 1998. High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF). NeXstar Pharmaceuticals, Inc., Boulder, CO, USA.
19. Gupta S, Thirstrup D, Jarvis TC, Schneider DJ, Wilcox SK, Carter J, Zhang C, Gelinas A, Weiss A, Janjic N, Baird GS. 2011. Rapid histochemistry using slow off-rate modified aptamers with anionic competition. Appl Immunohistochem Mol Morphol 19(3):273-278.
20. Hamula CLA, Zhang H, Guan LL, Li X-F, Le XC. 2008. Selection of aptamers against live bacterial cells. Anal Chem 80(20):7812-7819.
21. Harlow K, Pfundheller HM. 2010. Thermo Scientific Nunc immobilizer amino surface: Protocol for coupling proteins. Vedbaek, Denmark: Exiqon Laboratories. Technical Note No. 43.
22. Hesselberth JR, Robertson MP, Knudsen SM, Ellington AD. 2003. Simultaneous detection of diverse analytes with an aptazyme ligase array. Anal Biochem 312(2):106-112.
23. Hicke BJ, Watson SR, Koenig A, Lynott CK, Bargatze RF, Chang YF, Ringquist S, Moon-McDermott L, Jennings S, Fitzwater T, et al. 1996. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest 98(12):2688-2692.
24. Janssen KPF, Knez K, Pollet J, Roberts SJ, Schrooten J, Lammertyn J. 2011. Assay design considerations for use of affinity aptamer amplification in ultra-sensitive protein assays using capillary electrophoresis. Anal Methods 3(9):2156-2159.
25. Jarosch F, Buchner K, Klussmann S. 2006. In vitro selection using a dual RNA library that allows primerless selection. Nucleic Acids Res 34(12):e86.
26. Jayasena S. 1999. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45(9):1628-1650.
27. Jenison R, Gill S, Pardi A, Polisky B. 1994. High-resolution molecular discrimination by RNA. Science 263(5152):1425-1429.
28. Jeong S, Eom T-Y, Kim S-J, Lee S-W, Yu J. 2001. In vitro selection of the rna aptamer against the sialyl Lewis X and its inhibition of the cell adhesion. Biochem Biophys Res Commun 281(1):237-243.
29. Kanakaraj I, Chen WH, Poongavanam M, Dhamane S, Stagg LJ, Ladbury JE, Kourentzi K, Strych U, Willson RC. 2013. Biophysical characterization of VEGF-aHt DNA aptamer interactions. Int J Biol Macromol 57:69-75.
30. Kikuchi K, Umehara T, Fukuda K, Hwang J, Kuno A, Hasegawa T, Nishikawa S. 2003. RNA aptamers targeted to domain ii of hepatitis C virus IRES that bind to its apical loop region. J Biochem 133(3):263-270.
31. Lai Y-T, DeStefano JJ. 2011. A primer-free method that selects high-affinity single-stranded DNA aptamers using thermostable RNA ligase. Analy Biochem 414(2):246-253.
32. Latulippe DR, Szeto K, Ozer KA, Duarte FM, Kelly CV, Pagano JM, White BS, Shalloway D, Lis JT, Craighead HG. 2013. Multiplexed microcolumn-based process for efficient selection of RNA aptamers. Anal Chem 85:3417-3424.
33. Legiewicz M, Lozupone C, Knight R, Yarus M. 2005. Size, constant sequences, and optimal selection. RNA 11(11):1701-1709.
34. Legiewicz M, Yarus M. 2005. A more complex isoleucine aptamer with a cognate triplet. J Biol Chem 280(20):19815-19822.
35. Leva S, Lichte A, Burmeister J, Muhn P, Jahnke B, Fesser D, Erfurth J, Burgstaller P, Klussmann S. 2002. GnRH Binding RNA and DNA Spiegelmers: A novel approach toward GnRH Antagonism. Chem Biol 9(3):351-359.
36. Li JJ, Fang X, Tan W. 2002. Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun 292(1):31-40.
37. Liu J, Mazumdar D, Lu Y. 2006. A simple and sensitive "Dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures. Angew Chem Int Ed Engl 45(47):7955-7959.
38. Mannironi C, Di Nardo A, Fruscoloni P, Tocchini-Valentini GP. 1997. In vitro selection of dopamine RNA ligands. Biochemistry 36(32):9726-9734.
39. Mehta J, Rouah-Martin E, Van Dorst B, Maes B, Herrebout W, Scippo M-L, Dardenne F, Blust R, Robbens J. 2012. Selection and characterization of PCB-binding DNA aptamers. Anal Chem 84(3):1669-1676.
40. Minunni M, Tombelli S, Gullotto A, Luzi E, Mascini M. 2004. Development of biosensors with aptamers as bio-recognition element: The case of HIV-1 Tat protein. Biosens Bioelectron 20(6):1149-1156.
41. Moreau MJJ, Schaeffer PM. 2012. A polyplex qPCR-based binding assay for protein-DNA interactions. Analyst 137(18):4111-4113.
42. Mosing RK, Mendonsa SD, Bowser MT. 2005. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 77(19):6107-6112.
43. Niebel B, Wosnitza CI, Famulok M. 2013. RNA-aptamers that modulate the RhoGEF activity of Tiam1. Bioorg Med Chem 21(20):6239-6246.
44. Nimjee SM, Rusconi CP, Sullenger BA. 2005. Aptamers: An emerging class of therapeutics. Annu Rev Med 56(1):555-583.
45. Nonaka Y, Sode K, Ikebukuro K. 2010. Screening and improvement of an anti-VEGF DNA aptamer. Molecules 15(1):215-225.
46. Pan W, Clawson G. 2009. The shorter the better: Reducing fixed primer regions of oligonucleotide libraries for aptamer selection. Molecules 14(4):1353-1369.
47. Pan W, Xin P, Clawson GA. 2008. Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries. BioTechniques 44(3):351-360.
48. Pollard J, Bell SD, Ellington AD. 2001. Design, synthesis, and amplification of DNA pools for construction of combinatorial pools and libraries. In: Taylor GP, editor. Current protocols in molecular biology. New York, NY: John Wiley & Sons, Inc. p 24.2.1-24.2.24.
49. Qian J, Lou X, Zhang Y, Xiao Y, Soh HT. 2009. Generation of highly specific aptamers via micromagnetic selection. Anal Chem 81(13):5490-5495.
50. Rusconi CP, Scardino E, Layzer J, Pitoc GA, Ortel TL, Monroe D, Sullenger BA. 2002. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419(6902):90-94.
51. Sassanfar M, Szostak JW. 1993. An RNA motif that binds ATP. Nature 364(6437):550-553.
52. Schütze T, Wilhelm B, Greiner N, Braun H, Peter F, Mörl M, Erdmann VA, Lehrach H, Konthur Z, Menger M, et al. 2011. Probing the SELEX process with next-generation sequencing. PLoS ONE 6(12):e29604.
53. Shtatland T, Gill SC, Javornik BE, Johansson HE, Singer BS, Uhlenbeck OC, Zichi DA, Gold L. 2000. Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEX. Nucleic Acids Res 28(21):e93.
54. Siddiqui MAA, Keating GM. 2005. Pegaptanib: In exudative age-related macular degeneration. Drugs 65(11):1571-1577.
55. Stoltenburg R, Reinemann C, Strehlitz B. 2005. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 383(1):83-91.
56. Stoltenburg R, Reinemann C, Strehlitz B. 2007. SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24(4):381-403.
57. Tahiri-Alaoui A, Frigotto L, Manville N, Ibrahim J, Romby P, James W. 2002. High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucleic Acids Res 30(10):e45.
58. Tasset DM, Kubik MF, Steiner W. 1997. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol 272(5):688-698.
59. Tran DT, Janssen KPF, Pollet J, Lammertyn E, Ann J, Van Schepdael A, Lammertyn J. 2010. Selection and characterization of DNA aptamers for egg white lysozyme. Molecules 15(3):1127-1140.
60. Tuerk C, Gold L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249(4968):505-510.
61. Vater A, Jarosch F, Buchner K, Klussmann S. 2003. Short bioactive Spiegelmers to migraine associated calcitonin gene related peptide rapidly identified by a novel approach: Tailored SELEX. Nucleic Acids Res 31(21):e130.
62. Wang C, Yang G, Luo Z, Ding H. 2009. In vitro selection of high-affinity DNA aptamers for streptavidin. Acta Biochim Biophys Sin 41(4):335-340.
63. Wang J, Jiang H, Liu F. 2000. In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. RNA 6(04):571-583.
64. Wen J-D, Gray DM. 2004. Selection of genomic sequences that bind tightly to Ff gene 5 protein: Primer-free genomic SELEX. Nucleic Acids Res 32(22):e182.
65. Wilson R, Cossins A, Nicolau DV, Sotiris M. 2013. The selection of DNA aptamers for two different epitopes of thrombin was not due to different partitioning methods. Nucleic Acid Ther 23(1):88-92.
66. Wochner A, Menger M, Orgel D, Cech B, Rimmele M, Erdmann VA, Glökler J. 2008. A DNA aptamer with high affinity and specificity for therapeutic anthracyclines. Anal Biochem 373(1):34-42.
67. Xiao ZY, Levy-Nissenbaum E, Alexis F, Luptak A, Teply BA, Chan JM, Shi JJ, Digga E, Cheng J, Langer R, Farokhzad OC. 2012. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 6(1):696-704.
68. Zhang Z, Guo L, Guo A, Xu H, Tang J, Guo X, Xie J. 2010. In vitro lectin-mediated selection and characterization of rHuEPO-a-binding ssDNA aptamers. Bioorg Med Chem 18(22):8016-8025.
69. Zhou J, Battig M, Wang Y. 2010. Aptamer-based molecular recognition for biosensor development. Anal Bioanal Chem 398(6):2471-2480.
70. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31(13):3406-3415.